P01112 (RASH_HUMAN) Homo sapiens (Human)

GTPase HRas UniProtKBInterProSTRINGInteractive Modelling

189 aa; Sequence (Fasta) ; (Isoform 2); 42 identical sequences

Available Structures

233 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal Structure of the Afadin RA1 domain in complex with HRAS Heteromer
Q9QZQ1;
1-168
100GNP;MG;
CRYSTAL STRUCTURE OF THE ACTIVE RAS PROTEIN COMPLEXED WITH THE RAS-INTERACTING DOMAIN OF RALGDS Heteromer
Q03386;
1-167
99.4MG;GNP;
Tricomplex of RMC-7977, HRAS WT, and CypA Heteromer
P62937;
1-166
100GNP;MG;ZNI;
Crystal Structure of Mb(NS1)/H-Ras Complex Heteromer
1-166
100GDP;MG;
Crystal Structure of HRas(GMPPNP-bound) in complex with the Ras-binding domain(RBD) of SIN1 Heteromer
Q9BPZ7;
1-166
100GNP;MG;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;QTG;FMT;GOL;NA;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;FMT;QTD;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FWA;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FVM;FMT;GOL;NA;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;ACT;QTJ;FMT;GOL;NA;
Crystal Structure of HRasG12V(GMPPNP-bound) in complex with the Ras-binding domain(RBD) of SIN1 Heteromer
Q9BPZ7;
1-166
99.4GNP;MG;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FVJ;FMT;GOL;NA;
Crystal Structure of HRasQ61L(GMPPNP-bound) in complex with the Ras-binding domain(RBD) of SIN1 Heteromer
Q9BPZ7;
1-166
99.4GNP;MG;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FMT;FW7;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FFY;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FMT;FFS;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;EC4;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
100GNP;MG;EAS;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;EBY;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;CL;FVG;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FV4;FMT;GOL;NA;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;QTM;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;EBV;FMT;GOL;NA;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;QTA;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;EAV;FMT;GOL;NA;
Crystal Structure of NORE1A in Complex with RAS Heteromer
Q5EBH1;
1-166
98.8MG;GNP;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;QTV;FMT;GOL;NA;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;CL;FV7;FMT;GOL;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FFV;FMT;GOL;NA;
Expanding the Chemical Landscape of SOS1 Activators Using Fragment Based Methods Heteromer
Q07889;
1-166
99.4GNP;MG;FMT;QTS;GOL;NA;
Structure of PLC epsilon Ras association domain with hRas Heteromer
Q9P212;
1-166
99.4GTP;MG;GOL;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4GNP;MG;FMT;CL;FVD;GOL;BME;
Monobody 12VC3 Bound to HRAS(WT) Heteromer
1-166
100MG;GSP;
Ligand-bound Ras:SOS:Ras complex Heteromer
Q07889;
1-166
100MG;GNP;5UU;
Crystal structure of HRAS(G12V) - anti-RAS Fv complex Heteromer
1-166
99.4ZN;GTP;MG;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4MG;GNP;FVY;
Ligand-bound Ras:SOS:Ras complex Heteromer
Q07889;
1-166
100MG;GNP;5UX;
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4MG;GNP;FW4;
Transition state analogue complex of small G protein and its GAP effector Heteromer
P20936;
1-166
100GDP;MGF;MG;GAI;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100NEN;
Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange facto… Heteromer
Q07889;
1-166
99.4MG;PO4;GNP;
Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange facto… Heteromer
Q07889;
1-166
99.4MG;PO4;GTP;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100VJP;
Ligand-bound Ras:SOS:Ras complex Heteromer
Q07889;
1-166
100MG;GNP;5UV;
Crystal structure of the Grb14 RA and PH domains in complex with GTP-loaded H-Ras Heteromer
Q14449;
1-166
99.4GOL;GTP;MG;
Crystal structure of SOS1-HRas-peptidomimetic4 Heteromer
Q07889;
1-166
100FMT;
Crystal Structure of wt H-Ras-GppNHp bound to the RBD of Raf Kinase Heteromer
P04049;
1-166
100.0GNP;CA;MG;ACT;DTU;
Ligand-bound Ras:SOS:Ras complex Heteromer
Q07889;
1-166
100MG;GNP;5UW;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100RV1;
Crystal structure of SOS1-HRas-peptidomimetic10 Heteromer
Q07889;
1-166
100
Ras:SOS:Ras in complex with a small molecule activator Heteromer
Q07889;
1-166
99.4MG;GNP;FVV;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100L7S;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100FK1;HXY;FMT;
RAS-RASGAP COMPLEX Heteromer
P20936;
1-166
100MG;GDP;AF3;
Crystal structure of SOS1-HRas-peptidomimetic5 Heteromer
Q07889;
1-166
100CL; 14×FMT;
Monobody 12VC1 Bound to HRAS(G12C) Heteromer
1-166
99.4GSP;MG;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100FMT;UMK;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100L71;
Crystal Structure of a ternary Ras:SOS:Ras*GDP complex Heteromer
Q07889;
1-166
99.4MG;PO4;GDP;
Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange facto… Heteromer
Q07889;
1-166
100MG;PO4;GNP;
CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (disulfide free mutant) COMPLEX Heteromer
1-166
99.4ZN;GTP;MG;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
100DXO;
Crystal structure of HRas in complex with the Ras-binding and cysteine-rich domains of CRaf-kinase Heteromer
P04049;
1-166
99.4GNP;MG;ZN;
COMPLEX OF HUMAN H-RAS WITH HUMAN SOS-1 Heteromer
Q07889;
1-166
100
De novo design binder of HRAS -120-4 Heteromer
1-166
100GNP;MG;
The crystal structure of H-Ras and SOS in complex with ligands Heteromer
Q07889;
1-166
1006W2;
Approach for Targeting Ras with Small Molecules that Activate SOS-Mediated Nucleotide Exchange Heteromer
Q07889;
1-166
99.4MG;GNP;2PZ;
Crystal structure of SOS1-HRas-peptidomimetic2 Heteromer
Q07889;
1-166
100
Crystal Structure of G12V HRas-GppNHp bound in complex with the engineered RBD variant 1 of CRAF Ki… Heteromer
P04049;
1-166
99.4GNP;GOL;MG;
Approach for Targeting Ras with Small Molecules that Activate SOS-Mediated Nucleotide Exchange Heteromer
Q07889;
1-166
99.4MG;GNP;2PX;
Crystal structure of Ras-Bry2RBD complex Heteromer
P28829;
1-166
100MG;GNP;
Ras G12V - PI 3-kinase gamma complex Heteromer
P48736;
1-166
99.4MG;GNP;
Crystal structure of SOS1-HRas-peptidomimetic3 Heteromer
Q07889;
1-166
100.0
Crystal Structure of G12V HRas-GppNHp bound in complex with the engineered RBD variant 12 of CRAF K… Heteromer
P04049;
1-166
99.4MG;GNP;
Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange facto… Heteromer
Q07889;
1-166
99.4MG;GTP;PO4;
Crystal Structure of Q61L H-Ras-GppNHp bound to the RBD of Raf Kinase Heteromer
P04049;
1-166
99.4GNP;MG;
Crystal structure of Shank3 NTD-ANK A42K mutant in complex with HRas Heteromer
Q4ACU6; Q61411;
1-166
100GNP;MG;
Structure of RasGRP4 in complex with HRas Heteromer
Q8TDF6;
1-166
100.0
Approach for Targeting Ras with Small Molecules that Activate SOS-Mediated Nucleotide Exchange Heteromer
Q07889;
1-166
99.4MG;GNP;RND;
Complex of Ras-GDP with RafRBD(A85K) Heteromer
P04049;
1-165
100GDP;MG;
KRas G12V, bound to GppNHp and miniprotein 225-11 Heteromer
2-166
97.58GNP;MG;CA;
H-Ras PEG 400/CaCl2, ordered offhomo-6-mer1-166
99.412×CA; 12×MG;DTU;GNP;
MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS …homo-4-mer1-171
100MG;GCP;
H-Ras Q61H in complex with GppNHp (state 1) after structural transition by humidity controlhomo-3-mer1-166
99.37MG;NA;GNP;
CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GppNHphomo-3-mer1-166
98.815×MG;TRS;GNP;XY2;
CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND A…homo-2-mer1-171
99.42MG;GDP;
CRYSTAL STRUCTURES AT 2.2 ANGSTROMS RESOLUTION OF THE CATALYTIC DOMAINS OF NORMAL RAS PROTEIN AND A…homo-2-mer1-171
100MG;GDP;
HRas(1-166) in complex with GDP and BeF3-homo-2-mer1-166
100GDP;BEF;MG;MPD;
REFINED CRYSTAL STRUCTURE OF THE TRIPHOSPHATE CONFORMATION OF H-RAS P21 AT 1.35 ANGSTROMS RESOLUTIO…homo-2-mer1-166
100MG;GNP;
THREE-DIMENSIONAL STRUCTURES AND PROPERTIES OF A TRANSFORMING AND A NONTRANSFORMING GLYCINE-12 MUTA…homo-2-mer1-166
99.4MG;GNP;
STRUKTUR UND GUANOSINTRIPHOSPHAT-HYDROLYSEMECHANISMUS DES C-TERMINAL VERKUERZTEN MENSCHLICHEN KREBS…homo-2-mer1-166
100MG;GCP;
H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND …homo-2-mer1-166
98.8MG;GCP;
H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITH GUANOSINE-5'-[BETA,GAMMA-METHYLENE] TRIPHOSPHATE AND …homo-2-mer1-166
99.4MN;GCP;
X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED…homo-2-mer1-166
100MG;CAG;
Crystal Structure of H-Ras G12C, GMPPNP-boundhomo-2-mer1-166
99.4GNP;MG;CA;
THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION …homo-2-mer1-166
99.4MG;GNP;
THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION …homo-2-mer1-166
99.4MG;GNP;
THREE-DIMENSIONAL STRUCTURES AND PROPERTIES OF A TRANSFORMING AND A NONTRANSFORMING GLY-12 MUTANT O…homo-2-mer1-166
99.4MG;GNP;
THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION …homo-2-mer1-166
99.4MG;GNP;
THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION …homo-2-mer1-166
99.4MG;GNP;
X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED…homo-2-mer1-166
100MG;CAG;
THREE-DIMENSIONAL STRUCTURES OF H-RAS P21 MUTANTS: MOLECULAR BASIS FOR THEIR INABILITY TO FUNCTION …homo-2-mer1-166
98.8MG;GTP;
X-RAY CRYSTAL STRUCTURE ANALYSIS OF THE CATALYTIC DOMAIN OF THE ONCOGENE PRODUCT P21H-RAS COMPLEXED…homo-2-mer1-166
100MG;AGN;
CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY …homo-2-mer1-166
99.34MG;CAG;
CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY …homo-2-mer1-166
99.29MG;GTP;
CRYSTALLOGRAPHIC STUDIES ON P21H-RAS USING SYNCHROTRON LAUE METHOD: IMPROVEMENT OF CRYSTAL QUALITY …homo-2-mer1-166
99.38GDP;
HUMAN C-HA-RAS(1-171)(DOT)GDP, NMR, MINIMIZED AVERAGE STRUCTUREmonomer1-171
100MG;GDP;
MOLECULAR SWITCH FOR SIGNAL TRANSDUCTION: STRUCTURAL DIFFERENCES BETWEEN ACTIVE AND INACTIVE FORMS …monomer1-169
100MG;GDP;
Crystal Structure of the C-HA-RAS Protein Prepared by the Cell-Free Synthesismonomer1-169
100.0GDP;
Crystal structure of the GppNHp-bound H-Ras G60A mutantmonomer1-167
99.4MG;GNP;
CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GDPmonomer1-166
98.8MG;GDP;XY2;
Crystal structure analysis of a fluorescent form of H-Ras p21 in complex with R-caged GTPmonomer1-166
98.8MG;CAG;XY2;
CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GDP (2)monomer1-166
99.39MG;GDP;
CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH S-caged GTPmonomer1-166
98.8CAG;MG;XY2;
CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GTPmonomer1-166
98.8MG;XY2;GTP;
H-Ras mutant L120A bound to GMP-PNP at 100Kmonomer1-166
99.4GNP;CA;MG;NA;ACT;
STRUCTURE OF P21RAS IN COMPLEX WITH GPPNHP AT 100 Kmonomer1-166
100MG;GNP;
H-RasG12V with allosteric switch in the "on" statemonomer1-166
99.4GNP;CA;MG;ACT;
CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN COMPLEX WITH GTP (2)monomer1-166
98.8MG;XY2;GTP;
Allosteric modulation of H-Ras GTPasemonomer1-166
100GNP;CA;MG;ACT;
Room temperature H-rasmonomer1-166
100GNP;MG;
H-Ras PEG 400/Ca(OAc)2, ordered offmonomer1-166
99.4CA;MG;DTU;GNP;
H-RasQ61L with allosteric switch in the "on" statemonomer1-166
99.4GNP;CA;MG;ACT;
HRas (1-166) Y64 phosphorylationmonomer1-166
100.0GDP;MG;SO4;
Crystal structure of H-RasQ61K-GppNHpmonomer1-166
99.4CA;MG;GNP;
H-Ras mutant L120A bound to GMP-PNP at 277Kmonomer1-166
99.4CA;GNP;MG;
Crystal Structure of H-Ras with Thr50 replaced by Isoleucinemonomer1-166
99.4GNP;MG;CA;
H-Ras soaked in neat cyclopentanol: one of 10 in MSCS setmonomer1-166
100GNP;YEG;CA;MG;
Crystal structure of H-Ras-GppNHpmonomer1-166
100.0CA;MG;GNP;
H-Ras wildtype new crystal formmonomer1-166
100GNP;MG;CA;
Crystal structure of H-RasQ61I-GppNHp, trigonal crystal formmonomer1-166
100.0MG;GNP;
BeF3 Phospho-HRas GSA complexmonomer1-166
100PEG;ACT;GDP;BEF;MG;SO4;
HRAS R97L Crystal Form 2monomer1-166
99.4GNP;MG;
Crystal Structure of the activating H-RasK117R mutant in Costello Syndrome, bound to Mg-GDPmonomer1-166
99.4MG;GDP;
HRAS G12S in complex with GDPmonomer1-166
99.4GDP;MG;
Crystal Structure of the GTP-bound form of RasQ61Gmonomer1-166
99.4MG;CA;GNP;
H-Ras soaked in neat hexane: 1 of 10 in MSCS setmonomer1-166
100GNP;HEX;CA;MG;
HRAS A59E GDPmonomer1-166
99.4GDP;MG;CA;
H-Ras WT in complex with GppNHp (state 2*) before structural transition by humidity controlmonomer1-166
100GNP;CA;MG;
Set 1 CaCl2/DTT, ordered offmonomer1-166
99.4CA;MG;DTT;GNP;
Crystal Structure of Small Molecule Disulfide 2C07 Bound to H-Ras M72C GDPmonomer1-166
99.39GDP;92V;MG;
H-Ras Set 2 CaCl2/DTT, ordered offmonomer1-166
99.4CA;MG;GNP;DTT;
H-Ras Set 1 Ca(OAc)2, onmonomer1-166
100GNP;CA;MG;ACT;
Crystal structure of H-RasQ61V-GppNHpmonomer1-166
99.4MG;CA;GNP;
H-Ras soaked in 20% S,R,S-bisfuranol: 1 of 10 in MSCS setmonomer1-166
100GNP;CA;MG;RSG;
H-Ras crosslinked control, soaked in aqueous solution: one of 10 in MSCS setmonomer1-166
100GNP;CA;MG;
H-Ras in 70% glycerol: one of 10 in MSCS setmonomer1-166
100GNP;GOL;MG;CA;
STRUCTURE OF P21RAS IN COMPLEX WITH GTP AT 100 Kmonomer1-166
100MG;GTP;
H-Ras WT in complex with GppNHp (state 1) after structural transition by humidity controlmonomer1-166
100GNP;MG;CA;NA;
Crystal Structure of H-Ras G12C, GDP-boundmonomer1-166
99.37GDP;MG;CA;NA;
H-Ras bound to GMP-PNP at 277Kmonomer1-166
100CA;MG;NA;GNP;
HRAS R97G Crystal Form 2monomer1-166
99.4MG;GNP;CA;
H-Ras Set 2 Ca(OAc)2/DTE, ordered offmonomer1-166
99.4CA;MG;DTU;GNP;
H-Ras soaked in 55% dimethylformamide: 1 of 10 in MSCS setmonomer1-166
100GNP;DMF;CA;MG;
H-Ras Set 2 Ca(OAc)2, onmonomer1-166
100GNP;CA;MG;ACT;
HRAS R97A Crystal Form 1 T-Statemonomer1-166
99.4CA;MG;GNP;
Crystal Structure of RasA59G in the GDP-bound Formmonomer1-166
99.4MG;GDP;
Crystal Structure of the GDP-bound form of the RasG60A mutantmonomer1-166
99.4MG;GDP;
Crystal Structure of RasA59G in the GTP-bound formmonomer1-166
99.4MG;CA;GNP;
GTPase HRAS under 650 MPa pressuremonomer1-166
100GNP;MG;PGE;1PE;
H-Ras soaked in 50% isopropanol: 1 of 10 in MSCS setmonomer1-166
100.0GNP;CA;MG;
H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTPmonomer1-166
99.38MG;DBG;
H-Ras soaked in 60% 1,6-hexanediol: 1 of 10 in MSCS setmonomer1-166
100.0GNP;HEZ;MG;CA;
Crystal structure of H-Ras T35S in complex with GppNHpmonomer1-166
99.36GNP;MG;SO4;
H-Ras soaked in 90% R,S,R-bisfuranol: one of 10 in MSCS setmonomer1-166
100.0GNP; 13×RSF;MG;CA;
H-Ras Set 2 Ca(OAc)2/DTT, onmonomer1-166
100GNP;CA;MG;ACT;
H-Ras Set 1 CaCl2/DTE, ordered offmonomer1-166
99.4CA;MG;DTU;GNP;
HRAS R97M Crystal Form 2monomer1-166
99.4MG;GNP;CA;
GTPase HRAS under ambient pressuremonomer1-166
100GNP;MG;PGE;
HRAS A59T GppNHpmonomer1-166
99.4GNP;MG;GOL;
CRYSTAL STRUCTURE OF HRAS-G12D IN COMPLEX WITH GCP AND COMPOUND 18monomer1-166
99.38MG;GCP;EZZ;
GTPASE HRAS IN COMPLEX WITH ZN-CYCLEN AT AMBIENT PRESSUREmonomer1-166
100GNP;MG;PGE;
GTPase HRAS mutant D33K under 900 MPa pressuremonomer1-166
99.4GNP;MG;PGE;1PE;
HRAS R97F Crystal Form 1monomer1-166
99.36GNP;MG;CA;NA;
Allosteric modulation of H-Ras GTPasemonomer1-166
99.37CA;MG;GNP;
H-Ras Set 1 CaCl2 'Mixedmonomer1-166
100CA;MG;GNP;
H-Ras soaked in 50% 2,2,2-trifluoroethanol: one of 10 in MSCS setmonomer1-166
100GNP;ETF;CA;MG;
H-RasG12V with allosteric switch in the "off" statemonomer1-166
99.38GNP;CA;MG;DTT;
GTPase HRAS under 500 MPa pressuremonomer1-166
100GNP;MG;PGE;1PE;
HRAS R97L Crystal Form 1monomer1-166
99.4GNP;CA;MG;
Ras soaked in Calcium Acetatemonomer1-166
100GNP;CA;MG;ACT;
Ras soaked in Magnesium Acetatemonomer1-166
100GNP;CA;MG;
HRas G12V in complex with GDPmonomer1-166
99.4GDP;MG;CA;
H-Ras Y137Emonomer1-166
99.39MG;GNP;GOL;
GTPase HRAS under 200 MPa pressuremonomer1-166
100GNP;MG;PGE;
Crystal structure of H-RasQ61I-GppNHpmonomer1-166
99.4CA;MG;GNP;
Crystal structure of H-Ras G12V in complex with GppNHp (state 1)monomer1-166
99.4GNP;MG;
Crystal structure of H-Ras WT in complex with GppNHp (state 1)monomer1-166
100GNP;MG;
HRAS G13D bound to GppNHp (H13GNP)monomer1-166
99.39MG;GNP;CA;
H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA,GAMMA-IMIDO-GTPmonomer1-166
99.38MG;DBG;
HRAS R97G Crystal form 1monomer1-166
99.4MG;GNP;CA;
HRAS G13D bound to GppNHp (Ha,b,c13GNP)monomer1-166
99.37GNP;MG;CA;GOL;
GTPase HRAS mutant D33K under ambient pressuremonomer1-166
99.4GNP;MG;PGE;
HRAS G13D bound to GDP (H13GDP)monomer1-166
99.39GDP;MG;GOL;
HRAS R97M Crystal Form 1monomer1-166
99.4GNP;MG;DTT;CA;
HRAS R97I Crystal Form 1monomer1-166
99.4GNP;CA;MG;
H-Ras Q61L in complex with GppNHp (state 1) after structural transition by humidity controlmonomer1-166
99.4MG;CA;GNP;
HRAS A59E GppNHpmonomer1-166
99.37GNP;MG;GOL;
Structure of the Q61G mutant of Ras in the GDP-bound formmonomer1-166
99.4MG;GDP;
Crystal structure of H-RasQ61L-GppNHpmonomer1-166
99.4CA;MG;GNP;
H-Ras 166 in Aqueous mother liqour, RTmonomer1-166
100.0MG;GNP;
H-Ras in 50% isopropanolmonomer1-166
100.0MG;GNP;IPA;
Allosteric modulation of H-Ras GTPasemonomer1-166
99.39GNP;CA;MG;
Complex of Ras with cyclenmonomer1-166
100GNP;MG;CA;YCN;ZN;
CRYSTAL STRUCTURE OF HRAS IN COMPLEX WITH COMPOUND 18 and GDPmonomer1-166
100.0NA;GDP;EZZ;
H-Ras Y137Fmonomer1-166
99.38MG;GNP;CA;
GTPASE HRAS IN COMPLEX WITH ZN-CYCLEN AT 200 MPA PRESSUREmonomer1-166
100GNP;MG;PGE;
HRAS R97F Crystal Form 2monomer1-166
99.4MG;GNP;CA;
Ras soaked in Magnesium Acetate and back soaked in Calcium Acetatemonomer1-166
100GNP;CA;MG;ACT;
Crystal structure of H-Ras T35S in complex with GppNHpmonomer1-166
99.4GNP;MG;
GTPase HRAS mutant D33K under 200 MPa pressuremonomer1-166
99.4GNP;MG;PGE;
HRAS R97V Crystal Form 1monomer1-166
99.4GNP;CA;MG;
HRAS R97I Crystal Form 2monomer1-166
99.4GNP;MG;CA;
Crystal Structure of Small Molecule Disulfide 2C07 Bound to H-Ras M72C GppNHpmonomer1-166
99.36GNP;MG;
HRAS R97A Crystal Form 1 R-statemonomer1-166
99.4GNP;CA;MG;
H-RAS 166 in 60 % 1,6 hexanediolmonomer1-166
100MG;HEZ;GNP;
Crystal structure of H-Ras Q61L in complex with GppNHp (state 1)monomer1-166
99.4GNP;MG;
HRAS A59T GppNHp crystal 2monomer1-166
99.4GNP;MG;
H-Ras 166 in 50% 2,2,2 triflouroethanolmonomer1-166
100MG;GNP;ETF;
GTPase HRAS in complex with Zn-cyclen under 500 MPa pressuremonomer1-166
100GNP;MG;PGE;YCN;ZN;
Crystal structure of fully modified H-Ras-GppNHpmonomer1-166
100MG;CA;GNP;
Crystal Structure of the dominant negative S17N mutant of Rasmonomer1-166
99.31GDP;CA;
C-H-RAS P21 PROTEIN MUTANT WITH THR 35 REPLACED BY SER (T35S) COMPLEXED WITH GUANOSINE-5'-[B,G-IMID…monomer1-166
100.0MG;GNP;
THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIME…monomer1-166
100MG;GDP;
THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIME…monomer1-166
100MG;GDP;
EC-NMR Structure of Human H-RasT35S mutant protein Determined by Combining Evolutionary Couplings (…monomer1-166
99.4
Solution structure of H-RasT35S mutant protein in complex with Kobe2601monomer1-166
99.4GNP;MG;KOB;
THE SOLUTION STRUCTURE AND DYNAMICS OF RAS P21. GDP DETERMINED BY HETERONUCLEAR THREE AND FOUR DIME…monomer1-166
100MG;GDP;
Solution structure of GppNHp-bound H-RasT35S mutant proteinmonomer1-166
99.4GNP;MG;
Solution structure of H-RasT35S mutant protein in complex with KBFM123monomer1-166
99.4GNP;KBF;MG;
EC-NMR Structure of Human H-RasT35S mutant protein Determined by Combining Evolutionary Couplings (…monomer1-166
99.4
Neutron crystal structure of Ras bound to the GTP analogue GppNHpmonomer1-166
100.0GNP;MG;
Crystal Structure of the activating H-Ras I163F mutant in Costello Syndrome, bound to MG-GDPmonomer2-164
99.28GDP;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8elu.1.Amonomer0.881-166
MG;GNP;99.47

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 28elu.1.Amonomer0.861-165
MG;GNP;90.91